Controlled-release isosorbide dinitrate pellets. Part I: Design and evaluation of controlled-release capsule dosage form.
Design and evaluation of 8-h controlled-release isosorbide dinitrate capsules representing 20.0 and 40.0 mg of the drug are described. The formulation conforms to the total drug incorporated in the dosage form. In vitro dissolution studies indicate that the formulations behave as controlled-release dosage forms. Studies of storage at 30 +/- 2 and 40 +/- 2 degrees C at relative humidities of 72.0 and 90.0%, respectively, indicate that both temperature and humidity accelerate the degradation of the formulation. These results indicate the need of controlled packaging conditions during manufacture of these capsules.
Lalla
J K
JK
Department of Pharmaceutics, Principal K. M. Kundnani College of Pharmacy, Bombay, India.
Bhat
S U
SU
D001825:Body Fluid Compartments; D002626:Chemistry, Pharmaceutical; D003692:Delayed-Action Preparations; D004355:Drug Stability; D005069:Evaluation Studies as Topic; D007548:Isosorbide Dinitrate / Q000008:administration & dosage* / Q000737:chemistry; D007700:Kinetics; D008954:Models, Biological; D011108:Polymers
D003692:Delayed-Action Preparations; D011108:Polymers; D007548:Isosorbide Dinitrate